We are live on ! Find out more
WF

Welch & Forbes Portfolio holdings

AUM $8.23B
1-Year Est. Return 17.62%
This Fund
S&P 500
This Quarter Est. Return
+5.96%
1 Year Est. Return
+17.62%
3 Year Est. Return
+73.71%
5 Year Est. Return
+105.59%
10 Year Est. Return
+384.92%
AUM
$2.97B
AUM Growth
+$174M
Cap. Flow
+$25.7M
Cap. Flow %
0.86%
Top 10 Hldgs %
21.49%
Holding
341
New
21
Increased
129
Reduced
124
Closed
6

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$5.26M
2
BKLN icon
Invesco Senior Loan ETF
BKLN
+$5.07M
3
IRM icon
Iron Mountain
IRM
+$3.72M
4
MTD icon
Mettler-Toledo International
MTD
+$2.34M
5
DNB
Dun & Bradstreet
DNB
+$2.3M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$2.78M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.53M
3
EWY icon
iShares MSCI South Korea ETF
EWY
+$2.27M
4
IGSB icon
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
+$1.8M
5
EMR icon
Emerson Electric
EMR
+$1.02M

Sector Composition

Rank Sector Weight
1 Healthcare 16.25%
2 Technology 14.9%
3 Industrials 14.15%
4 Financials 9.71%
5 Energy 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
USB icon
76
US Bancorp
USB
$98.2B
$12.4M 0.42%
340,156
+53,158
+19% +$1.97M
IDXX icon
77
Idexx Laboratories
IDXX
$44.1B
$12.4M 0.42%
248,150
-6,000
-2% -$288K
UPS icon
78
United Parcel Service
UPS
$88.6B
$10.8M 0.36%
118,105
-31
-0% -$2.73K
CGNX icon
79
Cognex
CGNX
$10.9B
$10.7M 0.36%
683,612
-4,552
-0.7% -$63.7K
VWO icon
80
Vanguard FTSE Emerging Markets ETF
VWO
$121B
$10.2M 0.34%
253,956
-5,498
-2% -$218K
BRLI
81
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$10.2M 0.34%
340,200
-12,930
-4% -$360K
ABB
82
DELISTED
ABB Ltd
ABB
$10.1M 0.34%
428,957
-4,632
-1% -$104K
SVC
83
Service Properties Trust
SVC
$1.04B
$10.1M 0.34%
71,887
+1,308
+2% +$181K
BMY icon
84
Bristol-Myers Squibb
BMY
$133B
$10M 0.34%
216,166
+426
+0.2% +$18.7K
VEU icon
85
Vanguard FTSE All-World ex-US ETF
VEU
$66.6B
$9.84M 0.33%
202,377
+6,518
+3% +$306K
OVV icon
86
Ovintiv
OVV
$17.3B
$9.6M 0.32%
110,731
-3,056
-3% -$266K
NVS icon
87
Novartis
NVS
$297B
$9.55M 0.32%
138,926
-611
-0.4% -$40.4K
ORCL icon
88
Oracle
ORCL
$374B
$9.41M 0.32%
283,806
+1,829
+0.6% +$59.3K
CAT icon
89
Caterpillar
CAT
$375B
$9.19M 0.31%
110,168
-672
-0.6% -$56.8K
B
90
Barrick Mining
B
$61.5B
$8.88M 0.3%
476,987
-36,102
-7% -$637K
COP icon
91
ConocoPhillips
COP
$147B
$8.83M 0.3%
127,090
+2,265
+2% +$151K
BDX icon
92
Becton Dickinson
BDX
$45.6B
$8.46M 0.28%
86,648
+2,299
+3% +$225K
BKLN icon
93
Invesco Senior Loan ETF
BKLN
$6.97B
$8.12M 0.27%
328,840
+204,260
+164% +$5.07M
CTCT
94
DELISTED
CONSTANT CONTACT, INC COM
CTCT
$8.08M 0.27%
341,376
-2,369
-0.7% -$45.1K
LLY icon
95
Eli Lilly
LLY
$1.02T
$8.04M 0.27%
159,663
-966
-0.6% -$50.6K
PRGO icon
96
Perrigo
PRGO
$1.4B
$7.96M 0.27%
64,505
+4,527
+8% +$565K
EEM icon
97
iShares MSCI Emerging Markets ETF
EEM
$28.8B
$7.76M 0.26%
190,473
-5,255
-3% -$208K
PPO
98
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
$7.4M 0.25%
180,542
-2,025
-1% -$86.3K
SYY icon
99
Sysco
SYY
$40.8B
$7.27M 0.24%
228,472
-15,910
-7% -$534K
BNS icon
100
Scotiabank
BNS
$107B
$7.1M 0.24%
133,356
+5,687
+4% +$297K
2 3
4
5 6

Similar funds

OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return
LGF
LGT Group Foundation Vaduz, Liechtenstein $8.19B AUM 27.7% 1-Year Est. Return
CCM
Causeway Capital Management Los Angeles, California $8.15B AUM 29.28% 1-Year Est. Return
CL
Choreo LLC Rockford, Illinois $8.15B AUM 20.12% 1-Year Est. Return
WJWM
Williams Jones Wealth Management New York $8.14B AUM 19.32% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
CCM
Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Welch & Forbes's Q3 2013 Portfolio in Review

As of Q3 2013, Welch & Forbes held 341 positions worth $2.97B, up 6.2% from $2.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Welch & Forbes's Q3 2013 filing shows 21 new, 129 increased, 124 reduced and 6 closed positions. Its largest new stake was Edwards Lifesciences: 450,012 shares worth $5.22M. The largest sale was ExxonMobil, an estimated $2.78M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 16% a quarter earlier, followed by Technology and Industrials.

  • Welch & Forbes's largest Q3 2013 buy was Edwards Lifesciences: 450,012 shares worth $5.22M.
  • Welch & Forbes added most to Invesco Senior Loan ETF in Q3 2013, an estimated $5.07M increase.
  • Welch & Forbes's biggest Q3 2013 reduction was ExxonMobil, cutting an estimated $2.78M.
  • Welch & Forbes fully exited Aberdeen India Fund in Q3 2013, selling an estimated $339K.
  • Welch & Forbes's ten largest holdings make up 21% of its $2.97B portfolio in Q3 2013.
  • Welch & Forbes opened 21 new positions and closed 6 in Q3 2013.
  • Welch & Forbes's portfolio value rose 6.2% quarter-over-quarter to $2.97B.

Based on Welch & Forbes's 13F filing for Q3 2013, filed 31 Oct 2013.